Yates, Kathleen B.
Broad Institute · Harvard University · Massachusetts General Hospital
9 papers on CoChatORCID 0000-0002-7383-5573
Most cited papers
- Verified
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
Miller, B. C., Sen, D. R., Al Abosy, R., Bi, K., Virkud, Y. V., LaFleur, M. W., Yates, K. B., Lako, A., Felt, K., Naik, G. S., et al. (2019) · Nature Immunology
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 2,087
- Verified
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1,147
- Verified
The epigenetic landscape of T cell exhaustion
Sen, D. R., Kaminski, J., Barnitz, R. A., Kurachi, M., Gerdemann, U., Yates, K. B., Tsao, H.-W., Godec, J., LaFleur, M. W., Brown, F. D., et al. (2016) · Science
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 986
- Verified
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Deng, J., Wang, E. S., Jenkins, R. W., Li, S., Dries, R., Yates, K., Chhabra, S., Huang, W., Liu, H., Aref, A. R., et al. (2018) · Cancer Discovery
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 770
- Verified
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Ishizuka, J. J., Manguso, R. T., Cheruiyot, C. K., Bi, K., Panda, A., Iracheta-Vellve, A., Miller, B. C., Du, P. P., Yates, K. B., Dubrot, J., et al. (2019) · Nature
Cancer Immunotherapy and BiomarkersRNA regulation and disease
Cited by 697
- Verified
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity
Griffin, G. K., Wu, J., Iracheta-Vellve, A., Patti, J. C., Hsu, J., Davis, T., Dele-Oni, D., Du, P. P., Halawi, A. G., Ishizuka, J. J., et al. (2021) · Nature
Cancer Immunotherapy and BiomarkersEpigenetics and DNA Methylation
Cited by 370
- Verified
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Dubrot, J., Du, P. P., Lane-Reticker, S. K., Kessler, E. A., Muscato, A. J., Mehta, A., Freeman, S. S., Allen, P. M., Olander, K. E., Ockerman, K. M., et al. (2022) · Nature Immunology
Cancer Immunotherapy and BiomarkersImmune Cell Function and Interaction
Cited by 218
- Verified
Targeting TBK1 to overcome resistance to cancer immunotherapy
Sun, Y., Revach, O.-Y., Anderson, S., Kessler, E. A., Wolfe, C. H., Jenney, A., Mills, C. E., Robitschek, E. J., Davis, T. G. R., Kim, S., et al. (2023) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 174
- Verified
Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells
Yates, K., Bi, K., Haining, W. N., Cantor, H., & Kim, H.-J. (2018) · Proceedings of the National Academy of Sciences
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 55
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free